News | News By Subject | News by Disease News By Date | Search News

Psoriasis News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Samsung Bioepis Emerging as a Strong Player in the Autoimmune Space     7/20/2017
FDA Gives Nod to Johnson & Johnson (JNJ)'s Potential Blockbuster Psoriasis Med     7/17/2017
FDA Approval of Siliq for Psoriasis—How Will the Drug Perform in an Already Overcrowded Market?     2/22/2017
A Look at Amgen (AMGN) and Its $10 Billion Flop Onyx (AMGN)     11/3/2016
This Experimental Drug Could be Johnson & Johnson (JNJ)'s Next Blockbuster     10/7/2016
Sun Pharma (SUNPHARMA.NS), Almirall in $50 Million Psoriasis Drug Tie-Up     7/28/2016
FDA Panel Says Valeant (VRX)'s Psoriasis Med Should be Approved with Risk Plan     7/20/2016
FDA Panel Divided on Valeant (VRX)'s Psoriasis Drug Suicide Risk     7/18/2016
AbbVie (ABBV) Shows Off Positive HUMIRA Phase III Data in Moderate to Severe Fingernail Psoriasis     7/7/2016
Bay Area's XenoPort (XNPT) Snags Psoriasis and MS Deal Worth $490 Million+ from Dr. Reddy's Laboratories Ltd. (RDY)     3/28/2016
Eli Lilly (LLY) Wins FDA Approval for Psoriasis Drug Taltz     3/23/2016
Samsung Bioepis, Biogen (BIIB) Biosimilar is About to Take a Huge Chunk of Pfizer (PFE)'s Profits     11/20/2015
FDA Rejects Expanded Approval of Pfizer (PFE)'s Arthritis Drug Xeljanz     10/15/2015
Top 10 Best-Selling Biotech Drugs     10/2/2015
XenoPort (XNPT)'s Shares Jump After Psoriasis Treatment Meets Phase II Primary Endpoint     9/15/2015

News from Around the Web
How A $37,000-A-Year Medicine Sets A Good Model For Drug Pricing     4/4/2017
Why FDA Delay on Brodalumab is Actually Great News For Valeant (VRX)     11/30/2016
MorphoSys AG Moves Closer To Getting First Antibody Drug On Market     10/3/2016
Family History Biggest Predictor Of Heart Attacks In People With Psoriasis, University of Copenhagen Study     7/1/2016
Being Fat Ups Your Risk Of Getting This Skin Disease, University of Copenhagen Study     5/2/2016
Why It Feels So Good To Scratch An Itch, Published In Proceedings Of The Entomological Society Of Washington     2/29/2016
New Treatment for Psoriasis? Norwegian University of Science and Technology Study     1/14/2013
Analysis Links Psoriasis, Diabetes, University of California, Davis (UCD) Study     10/18/2012
Vigorous Exercise Might Keep Psoriasis at Bay, Brigham and Women's Hospital Study     5/22/2012
No Major Heart Risk Seen in New Psoriasis Drugs, Baylor Research Institute Study     8/24/2011
Study Sees Link Between Psoriasis, Obesity in Kids, Kaiser Permanente Reveals     5/23/2011
Antibody Efficacious in Psoriasis of the Hands and Feet, Central Dermatology Study     12/22/2010
Alcohol Linked to Psoriasis in Women, Harvard University Study     12/21/2010
NonLight Beer Consumption Linked to Psoriasis in Women, Brigham and Women's Hospital Study     8/17/2010
Psoriasis Linked To Higher Depression, Anxiety And Suicidal Feelings Risk, University of Pennsylvania Study     8/17/2010

Press Releases
Janssen R&D Release: New Two-Year TREMFYA (guselkumab) Data Show Patients With Moderate To Severe Plaque Psoriasis Achieved Consistent Rates Of Skin Clearance     9/18/2017
Dermira (DERM), UCB Group (UCBJF.PK) Release: New CIMZIA (Certolizumab Pegol) Findings Presented At European Academy Of Dermatology And Venereology (EADV) Congress     9/14/2017
Sandoz Proposed Biosimilar Adalimumab Matches Reference Biologic In Terms Of Efficacy And Safety In Long-Term Study     9/14/2017
Novartis AG (NVS) Posts Stunning 5-Year Sustained Late-Stage Psoriasis Data     9/13/2017
Dermira (DERM) Presents New Data On Late-Stage Programs At Leading European Dermatology Congress     9/7/2017
Ortho Dermatologics Submits New Drug Application To The FDA For Psoriasis Treatment IDP-118     9/5/2017
WHO Africa And IFPA Advocates For Psoriasis     9/1/2017
Innovation Pharma (Formerly known as Cellceutix) (CTIX) Completes Full Patient Enrollment In Phase IIb Study Of Prurisol For The Oral Treatment Of Psoriasis     8/28/2017
IMRALDI, Biogen (BIIB)’s Adalimumab Biosimilar Referencing Humira, Is Approved In The European Union     8/25/2017
Samsung Bioepis First To Obtain European Commission (EC) Approval For A Third Anti-TNF-? Biosimilar With Imraldi (Adalimumab)     8/25/2017
Dr. Reddy's Laboratories Ltd. (RDY) Announces The Out-Licensing Of DFD-06 To Encore Dermatology     8/22/2017
Can-Fite BioPharma (CFBI) Successfully Completes Human Cardiodynamic Safety Trial For Piclidenoson     8/7/2017
Pfizer (PFE) Release: FDA Advisory Committee Votes In Favor Of XELJANZ (Tofacitinib Citrate) For The Treatment Of Active Psoriatic Arthritis     8/4/2017
Valeant (VRX) Announces U.S. Launch Of SILIQ (Brodalumab) Injection     7/27/2017
UCB SA And Dermira (DERM) Announce U.S. And EU Regulatory Submissions For CIMZIA (Certolizumab Pegol) For The Treatment Of Moderate-To-Severe Chronic Plaque Psoriasis     7/25/2017